Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATG4AP1 stands for "Autophagy related 4A cysteine peptidase pseudogene 1" and is annotated as a pseudogene in human genomic resources[1]. Pseudogenes are sequences that resemble known genes but typically do not encode functional proteins. There is no evidence that ATG4AP1 is transcribed or translated into an active enzyme, receptor, or protein involved in autophagy or any other cellular process. Accordingly, ATG4AP1 is not considered a molecular target for therapeutics, biomarker discovery, or clinical interventions. The true functional autophagy-related peptidases are in the ATG4 family (for example, ATG4A, ATG4B, etc.), which are active cysteine proteases important in autophagy, but ATG4AP1 is a pseudogene and not an active member of this family[6][1]. There are currently no known drugs, associated diseases, biological functions, or safety concerns linked to ATG4AP1. Summary: There is something incorrect with the query as "ATG4AP1" is a pseudogene, not a functional drug target or receptor[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Autophagy related 4A cysteine peptidase pseudogene 1 (ATG4AP1).